Cipla share price
You have to be logged in to add this to Watchlist.- ₹1,398.50(-1.39%)May 29, 2026 15:48:54 PM IST
- NSE
- BSE
- Vol : 9.73 M (NSE + BSE)Last 20 day avg : 2.41 M
Cipla is trading -1.39% lower at Rs 1,398.50 as compared to its last closing price. Cipla has been trading in the price range of 1,429.00 & 1,384.60. Cipla has given -6.16% in this year & 1.34% in the last 5 days. Cipla has TTM P/E ratio 25.48 as compared to the sector P/E of 25.42.There are 37 analysts who have initiated coverage on Cipla. There are 7 analysts who have given it a strong buy rating & 15 analysts have given it a buy rating. 4 analysts have given the stock a sell rating.The company posted a net profit of 554.64 Crores in its last quarter.Listed peers of Cipla include Torrent Pharmaceuticals (-2.42%), Sun Pharmaceutical Industries (-2.39%), Lupin (-0.19%).The Mutual Fund holding in Cipla was at 18.66% in 31 Mar 2026. The MF holding has decreased from the last quarter. The FII holding in Cipla was at 22.55% in 31 Mar 2026. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on May 31, 2026, 05:40 PM UTC
- BetaLow volatility0.64Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.02The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldInline with the industry0.92Annual dividends as a percentage of the stock price.
- PEG RatioIndicates overvaluation2.58The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
- P/E-Price-to-earnings ratio based on trailing 12-month earnings
- P/B-The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | Bullish | 4,431.15 | -2.42 | 1,50,004.66 | 67.32 | 17.1 | 0.83 | 17.62 |
| Sun Pharmaceutical Industries | Neutral | 1,800.90 | -2.39 | 4,31,933.51 | 36.24 | 5.77 | 0.92 | 0.50 |
| Lupin | Neutral | 2,272.45 | -0.19 | 1,03,900.02 | 28.78 | 5.59 | 0.57 | 11.80 |
| Dr Reddy's Laboratories | Neutral | 1,302.95 | -1.22 | 1,08,746.54 | 18.63 | 3.14 | 0.63 | 2.34 |
| Divi's Laboratories | Neutral | 6,660.20 | -2.02 | 1,76,980.35 | 78.61 | 11.52 | 0.46 | 0.01 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-13 | Audited Results & Final Dividend |
| 2026-01-23 | Quarterly Results |
| 2025-10-30 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
- IndustryBiotechnology & Drugs
- ISININE059A01026
- BSE Code500087
- NSE CodeCIPLA
Cipla is trading at 1398.50 as on Fri May 29 2026 10:18:54. This is -1.39% lower as compared to its previous closing price of 1418.20.
The market capitalization of Cipla is 112970.91 Cr as on Fri May 29 2026 10:18:54.
The average broker rating on Cipla is Buy. The breakup of analyst rating is given below -
- 7 analysts have given a strong buy rating
- 15 analysts have given a buy rating
- 9 analysts have given a hold rating
- 4 analysts have given a sell rating
- 2 analysts have given a strong sell rating
The 52 wk high for Cipla is 1672.20 whereas the 52 wk low is 1165.55
Cipla can be analyzed on the following key metrics -
- TTM P/E: 25.48
- Sector P/E: 25.42
- Dividend Yield: 0.92%
- D/E ratio: 0.02
Cipla reported a net profit of 3879.23 Cr in 2026.
The Mutual Fund Shareholding was 18.66% at the end of 31 Mar 2026.
EQUITY QUICK LINKS
Cipla QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.